Both are studied as dual GLP-1/GIP receptor agonists, but they differ in trial stage, receptor activity profile, and the body of published data behind them
GLP-1 is able to stimulate cAMP formation in RIN 1046-38 cells, which in turn causes an increase in insulin mRNA levels and insulin release, and insulin accumulation in the culture fluid was observed by adding GLP-1 (7-37) to RIN 1046-38 cells for 1 h incubation (Mojsov et al., 1987)
Notes and reports from your GI specialist, including test results and imaging scans
Euglycemic ketoacidosis induced by therapeutic fasting in a non-diabetic patient
Because both forms are fast-acting, doctors usually choose the method based on safety, availability, and how predictable the response needs to be
Adding high-dose omega-3 fatty acids and polyphenols will reduce the other two types of inflammation that GLP-1 drugs cannot